PEG-coated gold nanoparticles attenuate β-adrenergic receptor-mediated cardiac hypertrophy

References

• YangLiZhangYYanBNanotoxicity overview: nano-threat to susceptible populationsInt J Mol Sci20141533671369724590128
   PubMed Web of Science ®Google Scholar
• ToyRBauerLHoimesCGhaghadaKBKarathanasisETargeted nanotechnology for cancer imagingAdv Drug Deliv Rev201476799725116445
   PubMed Web of Science ®Google Scholar
• SpivakMYBubnovRVYemetsIMLazarenkoLMTymoshokNOUlbergZRGold nanoparticles – the theranostic challenge for PPPM: nanocardiology applicationEPMA J2013411823800174
   PubMedGoogle Scholar
• HousniAZhaoYGold nanoparticles functionalized with block copolymers displaying either LCST or UCST thermosensitivity in aqueous solutionLangmuir20102615129331293920604503
   PubMed Web of Science ®Google Scholar
• LiuAYeBApplication of gold nanoparticles in biomedical researches and diagnosisClin Lab2013591–2233623505903
   PubMed Web of Science ®Google Scholar
• MieszawskaAJMulderWJFayadZACormodeDPMultifunctional gold nanoparticles for diagnosis and therapy of diseaseMol Pharm201310383184723360440
   PubMed Web of Science ®Google Scholar
• FergusonJFAllayeeHGersztenRENutrigenomics, the microbiome, and gene-environment interactions: new directions in cardiovascular disease research, prevention, and treatment: a scientific statement from the American Heart AssociationCirc Cardiovasc Genet20169329131327095829
   PubMedGoogle Scholar
• DavisMEHsiehPCTakahashiTLocal myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarctionProc Natl Acad Sci USA2006103218155816016698918
   PubMed Web of Science ®Google Scholar
• NagaokaKMatobaTMaoYA new therapeutic modality for acute myocardial infarction: nanoparticle mediated delivery of pitavastatin induces cardioprotection from ischemia-reperfusion injury via activation of PI3K/Akt pathway and anti-inflammation in a rat modelPLoS One2015107e013245126167913
   PubMed Web of Science ®Google Scholar
• SpivakMYBubnovRVYemetsIMLazarenkoLMTymoshokNOUlbergZRDevelopment and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiologyEPMA J2013412023889805
   PubMedGoogle Scholar
• BietenbeckMFlorianASechtemUYilmazAThe diagnostic value of iron oxide nanoparticles for imaging of myocardial inflammation – quo vadis?J Cardiovasc Magn Reson2015175426152269
   PubMed Web of Science ®Google Scholar
• YangCTianALiZReversible cardiac hypertrophy induced by PEG-coated gold nanoparticles in miceSci Rep201662020326830764
   PubMed Web of Science ®Google Scholar
• OkinPMDevereuxRBNieminenMSElectrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the losartan intervention for endpoint reduction in hypertension (LIFE) studyCirculation20061131677316365195
   PubMed Web of Science ®Google Scholar
• ShimizuIMinaminoTPhysiological and pathological cardiac hypertrophyJ Mol Cell Cardiol20169724526227262674
   PubMed Web of Science ®Google Scholar
• LiXMattaSMSullivanRDBahouthSWCarvedilol reverses cardiac insufficiency in AKAP5 knockout mice by normalizing the activities of calcineurin and CaMKIICardiovasc Res2014104227027925225170
   PubMed Web of Science ®Google Scholar
• NichtovaZNovotovaMKralovaEStankovicovaTMorphological and functional characteristics of models of experimental myocardial injury induced by isoproterenolGen Physiol Biophys201231214115122781817
   PubMed Web of Science ®Google Scholar
• KuokQYYehCYSuBCThe triterpenoids of Ganoderma tsugae prevent stress-induced myocardial injury in miceMol Nutr Food Res201357101892189623610080
   PubMed Web of Science ®Google Scholar
• RizziEGuimaraesDACeronCSβ1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophyFree Radic Biol Med20147330831724933619
   PubMed Web of Science ®Google Scholar
• WallnerMDuranJMMohsinSAcute Catecholamine exposure causes reversible myocyte injury without cardiac regenerationCirc Res2016119786587927461939
   PubMed Web of Science ®Google Scholar
• YangCYangHWuJNo overt structural or functional changes associated with PEG-coated gold nanoparticles accumulation with acute exposure in the mouse heartToxicol Lett2013222219720323906719
   PubMed Web of Science ®Google Scholar
• YangLJiaZYangKExercise protects against chronic β-adrenergic remodeling of the heart by activation of endothelial nitric oxide synthasePLoS One201495e9689224809512
   PubMed Web of Science ®Google Scholar
• YinQYangCWuJDownregulation of β-adrenoceptors in isoproterenol-induced cardiac remodeling through hurPLoS One2016114e015200527035432
   PubMed Web of Science ®Google Scholar
• ChowdhuryIThompsonWEThomasKProhibitins role in cellular survival through Ras-Raf-MEK-ERK pathwayJ Cell Physiol20142298998100424347342
   PubMed Web of Science ®Google Scholar
• VidalMWielandTLohseMJLorenzKβ-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathwayCardiovasc Res201296225526422843704
   PubMed Web of Science ®Google Scholar
• MoriscoCMarroneCGaleottiJEndocytosis machinery is required for β1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytesCardiovasc Res2008781364418194989
   PubMed Web of Science ®Google Scholar
• MoriscoCZebrowskiDCVatnerDEVatnerSFSadoshimaJβ-Adrenergic cardiac hypertrophy is mediated primarily by the β1-subtype in the rat heartJ Mol Cell Cardiol200133356157311181023
   PubMed Web of Science ®Google Scholar
• CuiYZhaoYTianYZhangWLüXJiangXThe molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coliBiomaterials20123372327233322182745
   PubMed Web of Science ®Google Scholar
• SinghVNairSPAradhyamGKChemistry of conjugation to gold nanoparticles affects G-protein activity differentlyJ Nanobiotechnology201311723510390
   PubMed Web of Science ®Google Scholar
• van VurenEJMalanLvon KänelRCockeranMMalanNTHyperpulsatile pressure, systemic inflammation and cardiac stress are associated with cardiac wall remodeling in an African male cohort: the SABPA studyHypertens Res201639964865327169396
   PubMed Web of Science ®Google Scholar
• ZhaoLChengGJinRDeletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunctionCirc Res2016118211918192927126808
   PubMedGoogle Scholar
• KumarSSethSJaiswalAChronic beta-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-alpha and IL-1-beta in ratsPharmacol Rep200961587087619904010
   PubMed Web of Science ®Google Scholar
• Nagoor MeeranMFJagadeeshGSSelvarajPThymol attenuates inflammation in isoproterenol induced myocardial infarcted rats by inhibiting the release of lysosomal enzymes and downregulating the expressions of proinflammatory cytokinesEur J Pharmacol201575415316125724787
   PubMed Web of Science ®Google Scholar
• GoebelMUMillsPJIrwinMRZieglerMGInterleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathwaysPsychosom Med200062459159810949106
   PubMed Web of Science ®Google Scholar
• ChenHDorriganASaadSHareDJCortieMBValenzuelaSMIn vivo study of spherical gold nanoparticles: inflammatory effects and distribution in micePloS One201382e5820823469154
   PubMed Web of Science ®Google Scholar
• GutkindGSOffermannsSA new G(q)-initiated MAPK signaling pathway in the heartDev Cell200916216316419217418
   PubMed Web of Science ®Google Scholar
• BuenoOFDe WindtLJTymitzKMThe MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic miceEMBO J200019236341635011101507
   PubMed Web of Science ®Google Scholar
• FuYXiaoHZhangYBeta-adrenoceptor signaling pathways mediate cardiac pathological remodelingFront Biosci (Elite Ed)201241625163722201979
   PubMedGoogle Scholar
• SonYCheongYKKimNHChungHTKangDGPaeHOMitogen-activated protein kinases species: how can ROS activate MAPK pathways?J Signal Transduct2011201179263921637379
   PubMedGoogle Scholar
• AradMSeidmanCESeidmanJGAMP-activated protein kinase in the heart: role during health and diseaseCirc Res2007100447448817332438
   PubMed Web of Science ®Google Scholar
• McCubreyJALahairMMFranklinRAReactive oxygen species-induced activation of the MAP kinase signaling pathwaysAntioxid Redox Signal200689–101775178916987031
   PubMed Web of Science ®Google Scholar
• DyckJRLopaschukGDAMPK alterations in cardiac physiology and pathology: enemy or ally?J Physiol2006574Pt 19511216690706
   PubMed Web of Science ®Google Scholar
• ShaheenTIEl-NaggarMEHusseinJSAntidiabetic assessment; in vivo study of gold and core-shell silver-gold nanoparticles on streptozotocin-induced diabetic ratsBiomed Pharmacother20168386587527505864
   PubMed Web of Science ®Google Scholar
• DkhilMABauomyAADiabMSAl-QuraishySAntioxidant and hepatoprotective role of gold nanoparticles against murine hepatic schistosomiasisInt J Nanomedicine2015107467747526719689
   PubMed Web of Science ®Google Scholar
• NegahdaryMChelongarRZadehSKAjdaryMThe antioxidant effects of silver, gold, and zinc oxide nanoparticles on male mice in in vivo conditionAdv Biomed Res201546925878994
   PubMedGoogle Scholar
• SelimMEAbd-ElhakimYMAl-AyadhiLYPancreatic response to gold nanoparticles includes decrease of oxidative stress and inflammation in autistic diabetic modelCell Physiol Biochem201535258660025612738
   PubMedGoogle Scholar
• TakahashiHNiidomeYNiidomeTKanekoKKawasakiHYamadaSModification of gold nanorods using phosphatidylcholine to reduce cytotoxicityLangmuir20062212516378388
   PubMed Web of Science ®Google Scholar
• PanYNeussSLeifertASize-dependent cytotoxicity of gold nanoparticlesSmall20073111941194917963284
   PubMed Web of Science ®Google Scholar
• VeroneseFMPasutGPEGylation, successful approach to drug deliveryDrug Discov Today200510211451145816243265
   PubMed Web of Science ®Google Scholar
• AlkilanyAMMurphyCJToxicity and cellular uptake of gold nanoparticles: what we have learned so far?J Nanopart Res20101272313233321170131
   PubMed Web of Science ®Google Scholar
• FadeelBGarcia-BennettAEBetter safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applicationsAdv Drug Deliv Rev201062336237419900497
   PubMed Web of Science ®Google Scholar